Carlos Andrés Pérez

6PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 16, 2025
Survival impact of adjuvant capecitabine in triple-negative breast cancer Latin American patients with residual disease: a real-world study.

Noiver Graciano, Lucelly López, Carlos A Rodriguez

|May 21, 2025
Effect of chemotherapy timing in triple-negative breast cancer: a real-world evidence study.

Noiver Graciano, Lucelly López, Carlos A Rodriguez

|Nov 12, 2024
Disseminated herpes simplex virus infection in pregnancy

Aida Oliveros, Paula Andrea Fonseca, Carlos Andrés Pérez

|Jan 25, 2023
Pharmacokinetic/Pharmacodynamic Index Linked to <i>In Vivo</i> Efficacy of the Ampicillin-Ceftriaxone Combination against Enterococcus faecalis.

Ivone Jimenez-Toro, Carlos A Rodriguez, Andres F Zuluaga

|Apr 14, 2017
CIEMTO: the new drug and poison research and information center in Medellín, Colombia.

Andres F Zuluaga, Carlos A Rodriguez, Sara Lastra-Bello

Pageof 1